Table of Contents Author Guidelines Submit a Manuscript
Contrast Media & Molecular Imaging
Volume 2017, Article ID 8598705, 7 pages
https://doi.org/10.1155/2017/8598705
Research Article

F-18 FP-CIT PET in Multiple System Atrophy of the Cerebellar Type: Additional Role in Treatment

1Department of Nuclear Medicine, Dong-A University Hospital, Dong-A University College of Medicine, Busan, Republic of Korea
2Institute of Convergence Bio-Health, Dong-A University, Busan, Republic of Korea
3Department of Neurology, Dong-A University Hospital, Dong-A University College of Medicine, Busan, Republic of Korea

Correspondence should be addressed to Sang-Myung Cheon; rk.ca.uad@noehcms

Received 16 October 2017; Accepted 14 November 2017; Published 29 November 2017

Academic Editor: Paulo H. Rosado-de-Castro

Copyright © 2017 Young Jin Jeong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Wenning, S. Gilman, and K. Seppi, “Second consensus statement on the diagnosis of multiple system atrophy,” Aktuelle Neurologie, vol. 35, no. S 01, 2008. View at Publisher · View at Google Scholar
  2. D. J. Lin, K. L. Hermann, and J. D. Schmahmann, “Multiple system atrophy of the cerebellar type: Clinical state of the art,” Movement Disorders, vol. 29, no. 3, pp. 294–304, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. K. A. Jellinger, “Neuropathology of multiple system atrophy: New thoughts about pathogenesis,” Movement Disorders, vol. 29, no. 14, pp. 1720–1741, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. G.-M. Kim, S. E. Kim, and W. Y. Lee, “Preclinical impairment of the striatal dopamine transporter system in sporadic olivopontocerebellar atrophy: Studied with [123I]β-CIT and SPECT,” European Neurology, vol. 43, no. 1, pp. 23–29, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Oh, J. S. Kim, J. Y. Kim et al., “Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy,” Journal of Nuclear Medicine, vol. 53, no. 3, pp. 399–406, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Jin, M. Oh, S. J. Oh et al., “Differential Diagnosis of Parkinsonism Using Dual-Phase F-18 FP-CIT PET Imaging,” Nuclear Medicine and Molecular Imaging, vol. 47, no. 1, pp. 44–51, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. H. Weng, M. C. Chen, R. S. Chen, K. Y. Tzen, and S. P. Wey, “99mTc-TRODAT-1 imaging of multiple system atrophy,” Journal of Nuclear Medicine, vol. 45, pp. 45–49, 2004. View at Google Scholar
  8. K. Van Laere, C. Casteels, L. De Ceuninck et al., “Dual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis,” Journal of Nuclear Medicine, vol. 47, no. 3, pp. 384–392, 2006. View at Google Scholar · View at Scopus
  9. G. El Fakhri, M.-O. Habert, P. Maksud et al., “Quantitative simultaneous 99mTc-ECD/123I-FP-CIT SPECT in Parkinson's disease and multiple system atrophy,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 33, no. 1, pp. 87–92, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Tripathi, V. Dhawan, S. Peng et al., “Differential diagnosis of parkinsonian syndromes using F-18 fluorodeoxyglucose positron emission tomography,” Neuroradiology, vol. 55, no. 4, pp. 483–492, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. S. M. Broski, C. H. Hunt, G. B. Johnson, R. F. Morreale, V. J. Lowe, and P. J. Peller, “Structural and functional imaging in parkinsonian syndromes,” RadioGraphics, vol. 34, no. 5, pp. 1273–1292, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Y. Kwon, J. S. Kim, K. C. Im, M. C. Lee, and S. J. Chung, “Comparison of cerebral glucose metabolism between possible and probable system atrophy,” Journal of Movement Disorders, vol. 2, pp. 22–28, 2009. View at Google Scholar
  13. L. Ciolli, F. Krismer, F. Nicoletti, and G. K. Wenning, “An update on the cerebellar subtype of multiple system atrophy,” Cerebellum & Ataxias, vol. 1, no. 1, 2014. View at Publisher · View at Google Scholar
  14. J. Wang, C. Zuo, Y. Jiang, Y. Guan, Z. Chen, and J. Xiang, “18F-FP-CIT PET imaging and SPM analysis of dopamine transporters in Parkinsons disease in various Hoehn & Yahr stages,” Journal of Neurology, vol. 254, pp. 185–190, 2007. View at Google Scholar
  15. S. A. Eshuis, R. P. Maguire, K. L. Leenders, S. Jonkman, and P. L. Jager, “Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 33, no. 2, pp. 200–209, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. I. Litvan, “Update on epidemiological aspects of progressive supranuclear palsy,” Movement Disorders, vol. 18, supplement 6, pp. S43–S50, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. H. T. S. Benamer, J. Patterson, D. J. Wyper, D. M. Hadley, G. J. A. Macphee, and D. G. Grosset, “Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake,” Movement Disorders, vol. 15, no. 4, pp. 692–698, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. C. L. Tomlinson, R. Stowe, S. Patel, C. Rick, R. Gray, and C. E. Clarke, “Systematic review of levodopa dose equivalency reporting in Parkinson's disease,” Movement Disorders, vol. 25, no. 15, pp. 2649–2653, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. J. Jeong, H. J. Son, H. J. Yoon, and D.-Y. Kang, “Functional volumetric analysis of striatum using F-18 FP-CIT PET in patients with idiopathic Parkinson’s disease and normal subjects,” Annals of Nuclear Medicine, vol. 30, no. 8, pp. 572–578, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Werner-Wasik, A. D. Nelson, W. Choi et al., “What is the best way to contour lung tumors on PET scans? Multiobserver validation of a gradient-based method using a NSCLC digital PET phantom,” International Journal of Radiation Oncology • Biology • Physics, vol. 82, no. 3, pp. 1164–1171, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Munoz, A. Iranzo, S. Rauek et al., “Subclinical nigrostriatal dopaminergic denervation in the cerebellar subtype of multiple system atrophy (MSA-C),” Journal of Neurology, vol. 258, no. 12, pp. 2248–2253, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. U. Wüllner, T. Schmitz-Hübsch, M. Abele, G. Antony, P. Bauer, and K. Eggert, “Features of probable multiple system atrophy patients identified among 4770 patients with parkinsonism enrolled in the multicentre registry of the German Competence Network on Parkinson's disease,” Journal of Neural Transmission, vol. 114, no. 9, pp. 1161–1165, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. K. A. Jellinger, K. Seppi, and G. K. Wenning, “Grading of neuropathology in multiple system atrophy: Proposal for a novel scale,” Movement Disorders, vol. 20, no. 12, pp. S29–S36, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Ozawa, D. Paviour, N. P. Quinn et al., “The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations,” Brain, vol. 127, no. 12, pp. 2657–2671, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. A. J. Stoessl, S. Lehericy, and A. P. Strafella, “Imaging insights into basal ganglia function, Parkinson's disease, and dystonia,” The Lancet, vol. 384, no. 9942, pp. 532–544, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. J. Kim, M. Ichise, J. R. Ballinger et al., “Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP,” Movement Disorders, vol. 17, no. 2, pp. 303–312, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Nissen, N. Malek, K. A. Grosset et al., “Baseline [123I]FP-CIT SPECT (DaTSCAN) severity correlates with medication use at 3 years in Parkinson's disease,” Acta Neurologica Scandinavica, vol. 129, no. 3, pp. 204–208, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Kazumata, V. Dhawan, T. Chaly et al., “Dopamine transporter imaging with fluorine-18-FPCIT and PET,” Journal of Nuclear Medicine, vol. 39, no. 9, pp. 1521–1530, 1998. View at Google Scholar · View at Scopus
  29. J. Lavalaye, J. Booij, L. Reneman, J. B. A. Habraken, and E. A. Van Royen, “Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 27, no. 7, pp. 867–869, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Osaki, Y. Ben-Shlomo, G. K. Wenning et al., “Do published criteria improve clinical diagnostic accuracy in multiple system atrophy?” Neurology, vol. 59, no. 10, pp. 1486–1491, 2002. View at Publisher · View at Google Scholar · View at Scopus